Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 3/20 | 0.73 |
| ▸ | CNR1 | P21554 | 2/20 | 0.73 |
| ▸ | HTR3A | P46098 | 10/20 | 0.57 |
| ▸ | HTR3E | A5X5Y0 | 4/20 | 0.57 |
| ▸ | HTR3B | O95264 | 4/20 | 0.57 |
| ▸ | HTR3D | Q70Z44 | 4/20 | 0.57 |
| ▸ | HTR3C | Q8WXA8 | 4/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9028063 | 0.89 | HTR3A (0.61) | CNR2CNR1HTR3AHTR3EHTR3B | |
| SCHEMBL9027144 | 0.88 | HTR3A (0.66) | CNR2CNR1HTR3AHTR3EHTR3B | |
| SCHEMBL22416267 | 0.87 | HTR3A (0.58) | CNR2CNR1HTR3AHTR3EHTR3B | |
| SCHEMBL16692891 | 0.87 | HTR3A (0.58) | CNR2CNR1HTR3AHTR3EHTR3B | |
| SCHEMBL9027739 | 0.87 | HTR3A (0.58) | CNR2CNR1HTR3AHTR3EHTR3B | |
| SCHEMBL9027450 | 0.86 | HTR3A (0.67) | CNR2CNR1HTR3AHTR3EHTR3B | |
| SCHEMBL9027784 | 0.86 | HTR3A (0.59) | CNR2CNR1HTR3AHTR3EHTR3B | |
| SCHEMBL16378030 | 0.85 | CNR1 (0.57) | CNR2CNR1HTR3AHTR3EHTR3B | |
| SCHEMBL22416052 | 0.85 | CNR1 (0.57) | CNR2CNR1HTR3AHTR3EHTR3B | |
| SCHEMBL9027809 | 0.85 | HTR3A (0.60) | CNR2CNR1HTR3AHTR3EHTR3B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0494978-B1 | HETEROCYCLIC COMPOUNDS | WYETH JOHN & BROTHER LTD (GB) | 1996-02-28 | — | — | EP | claimed |
| US-5096901-A | PHARMACOLOGICALLY ACTIVE AMIDES AND ESTERS CONTAINING AN AZABICYCLOALKANE MOIETY | JOHN WYETH & BROTHER LIMITED (GB) | 1992-03-17 | — | — | US | claimed |
| EP-0494978-B1 | HETEROCYCLIC COMPOUNDS | WYETH JOHN & BROTHER LTD (GB) | 1996-02-28 | — | — | EP | disclosed |
| US-5362734-A | Certain benzo-quinolizine compounds and derivatives thereof | AMERICAN HOME PRODUCTS CORPORATION (US) | 1994-11-08 | — | — | US | disclosed |
| US-5225419-A | Antagonist 5-hydroxytryptamine for treatment of nausea or vomiting | JOHN WYETH & BROTHER, LIMITED (GB) | 1993-07-06 | — | — | US | disclosed |
| EP-0494978-A1 | HETEROCYCLIC COMPOUNDS. | WYETH JOHN & BROTHER LTD (GB) | 1992-07-22 | — | — | EP | disclosed |
| US-5096901-A | PHARMACOLOGICALLY ACTIVE AMIDES AND ESTERS CONTAINING AN AZABICYCLOALKANE MOIETY | JOHN WYETH & BROTHER LIMITED (GB) | 1992-03-17 | — | — | US | disclosed |
| WO-1991005783-A1 | HETEROCYCLIC COMPOUNDS | JOHN WYETH & BROTHER LIMITED (GB) | 1991-05-02 | — | — | WO | disclosed |